График акции Turnstone Biologics Corp. Common Stock
Расширенный график
Простой график
О компании Turnstone Biologics Corp. Common Stock
Turnstone Biologics Corp., a clinical stage biotechnology company, focuses on developing medicines to treat and cure patients with solid tumors. The company's lead product includes TIDAL-01 that is in Phase 1 clinical trials for the treatment of breast cancer, colorectal cancer, head and neck cancer and uveal melanoma, as well as an investigator sponsored trials to treat colorectal cancer, head and neck cancer, and cutaneous and non-cutaneous melanomas. It is also developing TIDAL-02, which is in preclinical development for the treatment of solid tumors. подробнее| IPO date | 2023-07-21 |
|---|---|
| ISIN | US90042W1009 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://turnstonebio.com |
| Цена ао | 2.68 |
| Изменение цены за день: | +5.35% (0.48) |
|---|---|
| Изменение цены за неделю: | +2.97% (0.4911) |
| Изменение цены за месяц: | +0.1386% (0.505) |
| Изменение цены за 3 месяца: | -8.55% (0.553) |
| Изменение цены за полгода: | -78.11% (2.31) |
| Изменение цены за год: | -80.13% (2.545) |
| Изменение цены за 3 года: | 0% (0.5057) |
| Изменение цены за 5 лет: | 0% (0.5057) |
| Изменение цены за 10 лет: | 0% (0.5057) |
| Изменение цены с начала года: | -5.28% (0.5339) |
|
|
Недооценка
|
Эффективность
|
|||||||||||||||||||||||||||||||||||||
Дивиденды
|
Долг
|
Импульс роста
|
|||||||||||||||||||||||||||||||||||||
| Институционалы | Объем | Доля, % |
|---|---|---|
| Orbimed Advisors LLC. | 3099265 | 13.42 |
| FMR, LLC | 2546661 | 11.02 |
| Bank of America Corporation | 914058 | 3.96 |
| Point72 Asset Management, L.P. | 833333 | 3.61 |
| Eventide Asset Management LLC | 708317 | 3.07 |
| Citadel Advisors Llc | 688468 | 2.98 |
| PFM Health Sciences, LP | 633313 | 2.74 |
| 72 Investment Holdings, LLC | 549981 | 2.38 |
| Sectoral Asset Management, Inc. | 517648 | 2.24 |
| Blackrock Inc. | 301925 | 1.31 |
| ETF | Доля, % | Доходность за год, % | Дивиденды, % |
|---|---|---|---|
| iShares Micro-Cap ETF | 0.00268 | 17.09 | 1.54048 |
| Руководитель | Должность | Оплата | Год рождения |
|---|---|---|---|
| Dr. Sammy J. Farah M.B.A., Ph.D. | President, CEO & Director | 678.51k | 1973 (52 года) |
| Dr. Venkat Ramanan Ph.D. | Chief Financial Officer | 346.13k | 1970 (55 лет) |
| Dr. Michael F. Burgess M.D., MBChB, Ph.D. | Interim Chief Medical Officer & Executive Director | 212.69k | 1963 (62 года) |
| Ms. Saryah Azmat | Chief Business Officer | 479.73k | 1990 (35 лет) |
| Dr. Vijay Chiruvolu M.B.A., Ph.D. | Interim Chief Technology Officer | N/A | 1962 (63 года) |
| Dr. David Stojdl Ph.D. | Senior Vice President of Research & Discovery | ||
| Dr. Ines Verdon M.D. | Senior Vice President of Clinical Development |
Адрес: United States, LA Jolla. CA, 9310 Athena Circle - открыть в Google картах, открыть Яндекс картах
Сайт: https://turnstonebio.com
Сайт: https://turnstonebio.com
